The DOI matches its Crossref record; 330 of the 330 references it cites were found in a registry or an index.
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Machado, F. S., Esper, L., Dias, A., Madan, R., Gu, Y., Hildeman, D. A., Serhan, C. N., Karp, C. L., & Aliberti, J. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072416 · Cited by 47
Self-citationRetractedInternational Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Baumann, H., & Gauldie, J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90137-6 · Cited by 2,899
Inflammation. Basic principles and clinical correlates
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90156-x · Cited by 2,393
Diversity of G Proteins in Signal Transduction
Simon, M. I., Strathmann, M. P., & Gautam, N. (1991) · Science · doi:10.1126/science.1902986 · Cited by 2,014
De Lean, A., Stadel, J. M., & Lefkowitz, R. J. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)79672-9 · Cited by 1,612
Innate immune recognition: mechanisms and pathways
Medzhitov, R., & Janeway, C. J. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.917309.x · Cited by 1,506
β-Arrestin acts as a clathrin adaptor in endocytosis of the β2-adrenergic receptor
Goodman, O. B., Krupnick, J. G., Santini, F., Gurevich, V. V., Penn, R. B., Gagnon, A. W., Keen, J. H., & Benovic, J. L. (1996) · Nature · doi:10.1038/383447a0 · Cited by 1,384
MODEL SYSTEMS FOR THE STUDY OF SEVEN-TRANSMEMBRANE-SEGMENT RECEPTORS
Dohlman, H. G., Thorner, J., Caron, M. G., & Lefkowitz, R. J. (1991) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.60.070191.003253 · Cited by 1,379
G PROTEIN–COUPLED RECEPTOR KINASES
Pitcher, J. A., Freedman, N. J., & Lefkowitz, R. J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.653 · Cited by 1,361
Research works printed but not linked: 75
- Agarwal, 1989, Altered free cytosolic calcium changes and neutrophil chemotaxis in patients with juvenile periodontitis, J Periodontal Res, 24, 149, 10.1111/j.1600-0765.1989.tb00870.x · doi:10.1111/j.1600-0765.1989.tb00870.x
- Ali, 1993, Differences in phosphorylation of formylpeptide and C5a chemoattractant receptors correlate with differences in desensitization, J Biol Chem, 268, 24247, 10.1016/S0021-9258(20)80517-1 · doi:10.1016/s0021-9258(20)80517-1
- Allen, 1986, Preparation and properties of an improved photoaffinity ligand for the N-formyl peptide receptor, Biochim Biophys Acta, 882, 271, 10.1016/0304-4165(86)90248-5 · doi:10.1016/0304-4165(86)90248-5
- Aswanikumar, 1977, Demonstration of a receptor on rabbit neutrophils for chemotactic peptides, Biochem Biophys Res Commun, 74, 810, 10.1016/0006-291X(77)90375-8 · doi:10.1016/0006-291x(77)90375-8
- Bennett, 1980, The bacterial factors which stimulate neutrophils may be derived from procaryote signal peptides, FEBS Lett, 116, 57, 10.1016/0014-5793(80)80528-X · doi:10.1016/0014-5793(80)80528-x
- Bennett, 2001, Partial phosphorylation of the N-formyl peptide receptor inhibits G protein association independent of arrestin binding, J Biol Chem, 276, 49195, 10.1074/jbc.M106414200 · doi:10.1074/jbc.m106414200
- Bommakanti, 1995, Extensive contact between Gi2 and N-formyl peptide receptor of human neutrophils: mapping of binding sites using receptor-mimetic peptides, Biochemistry, 34, 6720, 10.1021/bi00020a017 · doi:10.1021/bi00020a017
- Bommakanti, 1993, A carboxyl-terminal tail peptide of neutrophil chemotactic receptor disrupts its physical complex with G protein, J Leukoc Biol, 54, 572, 10.1002/jlb.54.6.572 · doi:10.1002/jlb.54.6.572
- Boxer, 1979, Effects of a chemotactic factor, N-formylmethionyl peptide, on adherence, superoxide anion generation, phagocytosis, and microtubule assembly of human polymorphonuclear leukocytes, J Lab Clin Med, 93, 506
- Brazil, 1998, Priming induces functional coupling of N-formyl-methionyl-leucyl-phenylalanine receptors in equine neutrophils, J Leukoc Biol, 63, 380, 10.1002/jlb.63.3.380 · doi:10.1002/jlb.63.3.380
- Burg, 1995, G alpha-16 complements the signal transduction cascade of chemotactic receptors for complement factor C5a (C5a-R) and N-formylated peptides (fMLF-R) in Xenopus laevis oocytes: G alpha-16 couples to chemotactic receptors in Xenopus oocytes, FEBS Lett, 377, 426, 10.1016/0014-5793(95)01379-2 · doi:10.1016/0014-5793(95)01379-2
- Cassatella, 1992, IL-8 production by human polymorphonuclear leukocytes. The chemoattractant formyl-methionyl-leucyl-phenylalanine induces the gene expression and release of IL-8 through a pertussis toxin-sensitive pathway, J Immunol, 148, 3216, 10.4049/jimmunol.148.10.3216 · doi:10.4049/jimmunol.148.10.3216
- Chen, 1995, Tethered ligand library for discovery of peptide agonists, J Biol Chem, 270, 23398, 10.1074/jbc.270.40.23398 · doi:10.1074/jbc.270.40.23398
- Didsbury, 1991, Receptor class desensitization of leukocyte chemoattractant receptors, Proc Natl Acad Sci U S A, 88, 11564, 10.1073/pnas.88.24.11564 · doi:10.1073/pnas.88.24.11564
- Didsbury, 1992, Functional high efficiency expression of cloned leukocyte chemoattractant receptor cDNAs, FEBS Lett, 297, 275, 10.1016/0014-5793(92)80555-U · doi:10.1016/0014-5793(92)80555-u
- Dolmatch, 1983, Formyl peptide chemotactic receptor. Evidence for an active proteolytic fragment, J Biol Chem, 258, 7570, 10.1016/S0021-9258(18)32216-6 · doi:10.1016/s0021-9258(18)32216-6
- Donabedian, 1981, Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe, J Immunol, 127, 839, 10.4049/jimmunol.127.3.839 · doi:10.4049/jimmunol.127.3.839
- Finney, 1983, Ligand/receptor internalization: a kinetic, flow cytometric analysis of the internalization of N-formyl peptides by human neutrophils, Cytometry, 4, 54, 10.1002/cyto.990040108 · doi:10.1002/cyto.990040108
- Fiore, 1993, Induction of functional lipoxin A4 receptors in HL-60 cells, Blood, 81, 3395, 10.1182/blood.V81.12.3395.3395 · doi:10.1182/blood.v81.12.3395.3395
- Freer, 1982, Formyl peptide chemoattractants: a model of the receptor on rabbit neutrophils, Biochemistry, 21, 257, 10.1021/bi00531a009 · doi:10.1021/bi00531a009
- Fu, 2003, Subinhibitory concentrations of the deformylase inhibitor actinonin increase bacterial release of neutrophil-activating peptides: a new approach to antimicrobial chemotherapy, Antimicrob Agents Chemother, 47, 2545, 10.1128/AAC.47.8.2545-2550.2003 · doi:10.1128/aac.47.8.2545-2550.2003
- Furlan, 2004, The soluble D2D3(88–274) fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesion, J Cell Sci, 117, 2909, 10.1242/jcs.01149 · doi:10.1242/jcs.01149
- Gao, 2007, F2L, a peptide derived from heme-binding protein, chemoattracts mouse neutrophils by specifically activating Fpr2, the low-affinity N-formylpeptide receptor, J Immunol, 178, 1450, 10.4049/jimmunol.178.3.1450 · doi:10.4049/jimmunol.178.3.1450
- Gargiulo, 2005, Cross-talk between fMLP and vitronectin receptors triggered by urokinase receptor-derived SRSRY peptide, J Biol Chem, 280, 25225, 10.1074/jbc.M412605200 · doi:10.1074/jbc.m412605200
- Gierschik, 1989, Two distinct Gi-proteins mediate formyl peptide receptor signal transduction in human leukemia (HL-60) cells, J Biol Chem, 264, 21470, 10.1016/S0021-9258(20)88206-4 · doi:10.1016/s0021-9258(20)88206-4
- Gripentrog, 2000, Biochem J, 352, 399, 10.1042/bj3520399 · doi:10.1042/bj3520399
- Gripentrog, 2008, Variable responses of formyl peptide receptor haplotypes toward bacterial peptides, Immunogenetics, 60, 83, 10.1007/s00251-008-0277-3 · doi:10.1007/s00251-008-0277-3
- Grumbach, 2009, LXA4 stimulates ZO-1 expression and transepithelial electrical resistance in human airway epithelial (16HBE14o-) cells, Am J Physiol Lung Cell Mol Physiol, 296, L101, 10.1152/ajplung.00018.2008 · doi:10.1152/ajplung.00018.2008
- Gunji, 2007, Functional polymorphisms of the FPR1 gene and aggressive periodontitis in Japanese, Biochem Biophys Res Commun, 364, 7, 10.1016/j.bbrc.2007.09.105 · doi:10.1016/j.bbrc.2007.09.105
- He, 2001, Differential roles of the NPXXY motif in formyl peptide receptor signaling, J Immunol, 166, 4099, 10.4049/jimmunol.166.6.4099 · doi:10.4049/jimmunol.166.6.4099
- Hughes, 1992, Recruitment of CD11b/CD18 to the neutrophil surface and adherence-dependent cell locomotion, J Clin Invest, 90, 1687, 10.1172/JCI116041 · doi:10.1172/jci116041
- Kamal, 2006, Antiflammin-2 activates the human formyl-peptide receptor like 1, ScientificWorldJournal, 6, 1375, 10.1100/tsw.2006.247 · doi:10.1100/tsw.2006.247
- Karnad, 1989, Priming of human neutrophils with N-formyl-methionyl-leucyl-phenylalanine by a calcium-independent, pertussis toxin-insensitive pathway, Blood, 74, 2519, 10.1182/blood.V74.7.2519.2519 · doi:10.1182/blood.v74.7.2519.2519
- Kettritz, 1997, Neutrophil superoxide release is required for spontaneous and FMLP-mediated but not for TNF alpha-mediated apoptosis, J Am Soc Nephrol, 8, 1091, 10.1681/ASN.V871091 · doi:10.1681/asn.v871091
- Kim, 1993, N-linked glycosylation of the receptor for murine ecotropic retroviruses is altered in virus-infected cells, J Biol Chem, 268, 16316, 10.1016/S0021-9258(19)85423-6 · doi:10.1016/s0021-9258(19)85423-6
- Koo, 1982, The oligopeptide chemotactic factor receptor on human polymorphonuclear leukocyte membranes exists in two affinity states, Biochem Biophys Res Commun, 106, 442, 10.1016/0006-291X(82)91130-5 · doi:10.1016/0006-291x(82)91130-5
- Lad, 1977, Evidence for distinct guanine nucleotide sites in the regulation of the glucagon receptor and of adenylate cyclase activity, J Biol Chem, 252, 5942, 10.1016/S0021-9258(17)40009-3 · doi:10.1016/s0021-9258(17)40009-3
- Lehmeyer, 1979, Stimulation of neutrophil oxidative metabolism by chemotactic peptides: influence of calcium ion concentration and cytochalasin B and comparison with stimulation by phorbol myristate acetate, Blood, 54, 35, 10.1182/blood.V54.1.35.35 · doi:10.1182/blood.v54.1.35.35
- Linnekin, 1990, Migration of dog polymorphonuclear neutrophilic leukocytes to formylated peptides, Inflammation, 14, 691, 10.1007/BF00916372 · doi:10.1007/bf00916372
- Maestes, 1999, Differential phosphorylation paradigms dictate desensitization and internalization of the N-formyl peptide receptor, J Biol Chem, 274, 29791, 10.1074/jbc.274.42.29791 · doi:10.1074/jbc.274.42.29791
- Malech, 1985, Asparagine-linked oligosaccharides on formyl peptide chemotactic receptors of human phagocytic cells, J Biol Chem, 260, 2509, 10.1016/S0021-9258(18)89582-5 · doi:10.1016/s0021-9258(18)89582-5
- McCoy, 1995, N-formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation, J Exp Med, 182, 207, 10.1084/jem.182.1.207 · DOI
- Miao, 2007, Proinflammatory proteases liberate a discrete high-affinity functional FPRL1 (CCR12) ligand from CCL23, J Immunol, 178, 7395, 10.4049/jimmunol.178.11.7395 · doi:10.4049/jimmunol.178.11.7395
- Miettinen, 1999, Identification of putative sites of interaction between the human formyl peptide receptor and G protein, J Biol Chem, 274, 27934, 10.1074/jbc.274.39.27934 · doi:10.1074/jbc.274.39.27934
- Miettinen, 1997, The ligand binding site of the formyl peptide receptor maps in the transmembrane region, J Immunol, 159, 4045, 10.4049/jimmunol.159.8.4045 · doi:10.4049/jimmunol.159.8.4045
- Mills, 1998, Identification of a ligand binding site in the human neutrophil formyl peptide receptor using a site-specific fluorescent photoaffinity label and mass spectrometry, J Biol Chem, 273, 10428, 10.1074/jbc.273.17.10428 · doi:10.1074/jbc.273.17.10428
- Nanamori, 2004, Normal cell surface expression and selective loss of functions resulting from Phe110 to Ser and Cys126 to Trp substitutions in the formyl peptide receptor, Immunol Invest, 33, 193, 10.1081/IMM-120034234 · doi:10.1081/imm-120034234
- Niedel, 1980, Covalent affinity labeling of the formyl peptide chemotactic receptor, J Biol Chem, 255, 7063, 10.1016/S0021-9258(20)79659-6 · doi:10.1016/s0021-9258(20)79659-6
- Niedel, 1980, A subpopulation of cultured human promyelocytic leukemia cells (HL-60) displays the formyl peptide chemotactic receptor, Proc Natl Acad Sci U S A, 77, 1000, 10.1073/pnas.77.2.1000 · doi:10.1073/pnas.77.2.1000
- Niggli, 1997, The phosphatidylinositol 3-kinase inhibitor wortmannin markedly reduces chemotactic peptide-induced locomotion and increases in cytoskeletal actin in human neutrophils, Eur J Pharmacol, 335, 43, 10.1016/S0014-2999(97)01169-2 · doi:10.1016/s0014-2999(97)01169-2
- Olofsson, 1980, Altered kinetic properties of sialyl and galactosyl transferases associated with herpes simplex virus infection of GMK and BHK cells, J Gen Virol, 47, 1, 10.1099/0022-1317-47-1-1 · doi:10.1099/0022-1317-47-1-1
- Oseas, 1980, Differences in polymorphonuclear leukocyte aggregating responses among several species in response to chemotactic stimulation, J Lab Clin Med, 96, 213
- Posner, 1994, Continuous spectrofluorometric analysis of formyl peptide receptor ternary complex interactions, Mol Pharmacol, 45, 65, 10.1016/S0026-895X(25)09905-5 · doi:10.1016/s0026-895x(25)09905-5
- Prossnitz, 1991, Transmembrane signalling by the N-formyl peptide receptor in stably transfected fibroblasts, Biochem Biophys Res Commun, 179, 471, 10.1016/0006-291X(91)91394-R · doi:10.1016/0006-291x(91)91394-r
- Prossnitz, 1995, Binding of low affinity N-formyl peptide receptors to G protein. Characteriztion of a novel inactive receptor intermediate, J Biol Chem, 270, 10686, 10.1074/jbc.270.18.10686 · doi:10.1074/jbc.270.18.10686
- Rot, 1989, Staphylococcus aureus tetrapeptide with high chemotactic potency and efficacy for human leukocytes, J Leukoc Biol, 45, 114, 10.1002/jlb.45.2.114 · doi:10.1002/jlb.45.2.114
- Schreiber, 1994, Domains of the human neutrophil N-formyl peptide receptor involved in G protein coupling. Mapping with receptor-derived peptides, J Biol Chem, 269, 326, 10.1016/S0021-9258(17)42352-0 · doi:10.1016/s0021-9258(17)42352-0
- Schreiber, 1993, Reconstitution of recombinant N-formyl chemotactic peptide receptor with G protein, J Leukocyte Biol, 53, 470, 10.1002/jlb.53.4.470 · doi:10.1002/jlb.53.4.470
- Schultz, 1992, Complementation of formyl peptide receptor-mediated signal transduction in Xenopus laevis oocytes, Biochem J, 284, 207, 10.1042/bj2840207 · doi:10.1042/bj2840207
- Sha’afi, 1988, Activation of the neutrophil, Prog Allergy, 42, 1
- Sklar, 1987, Regulation of ligand-receptor dynamics by guanine nucleotides. Real-time analysis of interconverting states for the neutrophil formyl peptide receptor, J Biol Chem, 262, 135, 10.1016/S0021-9258(19)75899-2 · doi:10.1016/s0021-9258(19)75899-2
- Sklar, 1990, Fluorescence analysis of the size of a binding pocket of a peptide receptor at natural abundance, Biochemistry, 29, 313, 10.1021/bi00454a002 · doi:10.1021/bi00454a002
- Sklar, 1982, Analysis of ligand-receptor interactions with the fluorescence activated cell sorter, Cytometry, 3, 161, 10.1002/cyto.990030304 · doi:10.1002/cyto.990030304
- Sklar, 1981, Fluoresceinated chemotactic peptide and high-affinity antifluorescein antibody as a probe of the temporal characteristics of neutrophil stimulation, Proc Natl Acad Sci U S A, 78, 7540, 10.1073/pnas.78.12.7540 · doi:10.1073/pnas.78.12.7540
- Smith, 1988, Diacylglycerols modulate human polymorphonuclear neutrophil responsiveness: effects on intracellular calcium mobilization, granule exocytosis, and superoxide anion production, J Leukoc Biol, 43, 411, 10.1002/jlb.43.5.411 · doi:10.1002/jlb.43.5.411
- Snyderman, 1980, N-Formylmethionyl peptide receptors on equine leukocytes initiate secretion but not chemotaxis, Science, 209, 493, 10.1126/science.6248959 · doi:10.1126/science.6248959
- Toniolo, 1990, N alpha-formylated and tert-butyloxycarbonylated Phe-(Leu-Phe)n and (Leu-Phe)n peptides as agonists and antagonists of the chemotactic formylpeptide receptor of the rabbit peritoneal neutrophil, Biochim Biophys Acta, 1034, 67, 10.1016/0304-4165(90)90154-O · doi:10.1016/0304-4165(90)90154-o
- Verghese, 1987, Role of a guanine nucleotide regulatory protein in the activation of phospholipase C by different chemoattractants, J Immunol, 138, 4374, 10.4049/jimmunol.138.12.4374 · doi:10.4049/jimmunol.138.12.4374
- Villanueva, 1994, Infection with Listeria monocytogenes impairs sialic acid addition to host cell glycoproteins, J Exp Med, 180, 2137, 10.1084/jem.180.6.2137 · doi:10.1084/jem.180.6.2137
- von Wartburg, 1986, Chemistry of the natural cyclosporin metabolites, Prog Allergy, 38, 28
- Ward, 1984, Rat neutrophil activation and effects of lipoxygenase and cyclooxygenase inhibitors, Am J Pathol, 116, 223
- Wenzel-Seifert, 1991, Differential inhibition of human neutrophil activation by cyclosporins A, D, and H. Cyclosporin H is a potent and effective inhibitor of formyl peptide-induced superoxide formation, J Immunol, 147, 1940, 10.4049/jimmunol.147.6.1940 · doi:10.4049/jimmunol.147.6.1940
- Wilkinson, 1979, Synthetic peptide chemotactic factors for neutrophils: the range of active peptides, their efficacy and inhibitory activity, and susceptibility of the cellular response to enzymes and bacterial toxins, Immunology, 36, 579
- Yan, 2006, The immunosuppressant cyclosporin A antagonizes human formyl peptide receptor through inhibition of cognate ligand binding, J Immunol, 177, 7050, 10.4049/jimmunol.177.10.7050 · doi:10.4049/jimmunol.177.10.7050
- Zhou, 2007, Pharmacological characterization of a novel nonpeptide antagonist for formyl peptide receptor-like 1, Mol Pharmacol, 72, 976, 10.1124/mol.107.037564 · doi:10.1124/mol.107.037564
Cited by
Neutrophil recruitment and function in health and inflammation
Kolaczkowska, E., & Kubes, P. (2013) · Nature Reviews Immunology · doi:10.1038/nri3399 · Cited by 5,472
Phagocyte partnership during the onset and resolution of inflammation
Soehnlein, O., & Lindbom, L. (2010) · Nature Reviews Immunology · doi:10.1038/nri2779 · Cited by 1,054
Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation
Krysko, D. V., Agostinis, P., Krysko, O., Garg, A. D., Bachert, C., Lambrecht, B. N., & Vandenabeele, P. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.01.005 · Cited by 680
Neutrophil cell surface receptors and their intracellular signal transduction pathways
Futosi, K., Fodor, S., & Mócsai, A. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.06.034 · Cited by 642
Neutrophil chemoattractant receptors in health and disease: Double-edged swords
Metzemaekers, M., Gouwy, M., & Proost, P. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0412-0 · Cited by 570
GPCR-Mediated Signaling of Metabolites
Husted, A. S., Trauelsen, M., Rudenko, O., Hjorth, S. A., & Schwartz, T. W. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.03.008 · Cited by 590
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
Panula, P., Chazot, P. L., Cowart, M., Gutzmer, R., Leurs, R., Liu, W. L. S., Stark, H., Thurmond, R. L., & Haas, H. L. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.010249 · Cited by 575
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation
Chen, Y., & Yu, Y. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02853-3 · Cited by 516
“They are known initially as orphan receptors and recognize various endogenous and exogenous chemotactic ligands to exert pro-inflammatory or antiinflammatory functions [146, 147].”
BackgroundMultiple Roles for Neutrophils in Atherosclerosis
Soehnlein, O. (2012) · Circulation Research · doi:10.1161/circresaha.111.257535 · Cited by 498
Phenol-soluble modulins and staphylococcal infection
Peschel, A., & Otto, M. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3110 · Cited by 452
Novel Lipid Mediators and Resolution Mechanisms in Acute Inflammation
Serhan, C. N. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100322 · Cited by 421
Self-citationSugimoto, M. A., Vago, J. P., Teixeira, M. M., & Sousa, L. P. (2016) · Journal of Immunology Research · doi:10.1155/2016/8239258 · Cited by 414
Mitochondria in innate immune signaling
Banoth, B., & Cassel, S. L. (2018) · Translational Research · doi:10.1016/j.trsl.2018.07.014 · Cited by 410
The resolution of inflammation: Principles and challenges
Headland, S. E., & Norling, L. V. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.03.014 · Cited by 410
Novel Lipid Mediators Promote Resolution of Acute Inflammation: Impact of Aspirin and Statins
Spite, M., & Serhan, C. N. (2010) · Circulation Research · doi:10.1161/circresaha.110.223883 · Cited by 365
Self-citationLeoni, G., Neumann, P.-A., Kamaly, N., Quiros, M., Nishio, H., Jones, H. R., Sumagin, R., Hilgarth, R. S., Alam, A., Fredman, G., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76693 · Cited by 354
DAMPs, MAMPs, and NAMPs in plant innate immunity
Choi, H. W., & Klessig, D. F. (2016) · BMC Plant Biology · doi:10.1186/s12870-016-0921-2 · Cited by 349
Marques, P. E., Amaral, S. S., Pires, D. A., Nogueira, L. L., Soriani, F. M., Lima, B. H. F., Lopes, G. A. O., Russo, R. C., Ávila, T. V., Melgaço, J. G., et al. (2012) · Hepatology · doi:10.1002/hep.25801 · Cited by 332
Emerging functions of serum amyloid A in inflammation
Ye, R. D., & Sun, L. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3vmr0315-080r · Cited by 311
Self-citationDe Santo, C., Arscott, R., Booth, S., Karydis, I., Jones, M., Asher, R., Salio, M., Middleton, M., & Cerundolo, V. (2010) · Nature Immunology · doi:10.1038/ni.1942 · Cited by 304
Dufton, N., Hannon, R., Brancaleone, V., Dalli, J., Patel, H. B., Gray, M., D’Acquisto, F., Buckingham, J. C., Perretti, M., & Flower, R. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903526 · Cited by 302
Endocannabinoids and Their Pharmacological Actions
Pertwee, R. G. (2015) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-319-20825-1_1 · Cited by 300
Cooray, S. N., Gobbetti, T., Montero-Melendez, T., McArthur, S., Thompson, D., Clark, A. J. L., Flower, R. J., & Perretti, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308253110 · Cited by 299
Resolution of Acute Inflammation in the Lung
Levy, B. D., & Serhan, C. N. (2014) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021113-170408 · Cited by 298
Self-citationAnnexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair
Leoni, G., Alam, A., Neumann, P.-A., Lambeth, J. D., Cheng, G., McCoy, J., Hilgarth, R. S., Kundu, K., Murthy, N., Kusters, D., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65831 · Cited by 295
Human Formyl Peptide Receptor 2 Senses Highly Pathogenic Staphylococcus aureus
Kretschmer, D., Gleske, A.-K., Rautenberg, M., Wang, R., Köberle, M., Bohn, E., Schöneberg, T., Rabiet, M.-J., Boulay, F., Klebanoff, S. J., et al. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.05.012 · Cited by 282
Self-citationThe Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition
He, H.-Q., & Ye, R. (2017) · Molecules · doi:10.3390/molecules22030455 · Cited by 279
Self-citationNovel Anti-Inflammatory-Pro-Resolving Mediators and Their Receptors
N. Serhan, C., Krishnamoorthy, S., Recchiuti, A., & Chiang, N. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611109060629 · Cited by 276
The role of non-resolving inflammation in atherosclerosis
Kasikara, C., Doran, A. C., Cai, B., & Tabas, I. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97950 · Cited by 266
Key mechanisms governing resolution of lung inflammation
Robb, C. T., Regan, K. H., Dorward, D. A., & Rossi, A. G. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0560-6 · Cited by 261
Dorward, D. A., Lucas, C. D., Chapman, G. B., Haslett, C., Dhaliwal, K., & Rossi, A. G. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2015.01.020 · Cited by 258
Inflammation activation and resolution in human tendon disease
Dakin, S. G., Martinez, F. O., Yapp, C., Wells, G., Oppermann, U., Dean, B. J. F., Smith, R. D. J., Wheway, K., Watkins, B., Roche, L., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac4269 · Cited by 253
Microglial Aβ Receptors in Alzheimer’s Disease
Yu, Y., & Ye, R. D. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0101-6 · Cited by 247
Self-citationUpdate on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7
Bäck, M., Powell, W. S., Dahlén, S., Drazen, J. M., Evans, J. F., Serhan, C. N., Shimizu, T., Yokomizo, T., & Rovati, G. E. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12665 · Cited by 217
Self-citationPleiotropic regulation of macrophage polarization and tumorigenesis by formyl peptide receptor-2
Li, Y., Cai, L., Wang, H., Wu, P., Gu, W., Chen, Y., Hao, H., Tang, K., Yi, P., Liu, M., et al. (2011) · Oncogene · doi:10.1038/onc.2011.112 · Cited by 192
Medeiros, R., Kitazawa, M., Passos, G. F., Baglietto-Vargas, D., Cheng, D., Cribbs, D. H., & LaFerla, F. M. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.01.051 · Cited by 163
Role of gut microbiota in intestinal wound healing and barrier function
Alam, A., & Neish, A. (2018) · Tissue Barriers · doi:10.1080/21688370.2018.1539595 · Cited by 166
The BLUEPRINT Data Analysis Portal
Fernández, J. M., de la Torre, V., Richardson, D., Royo, R., Puiggròs, M., Moncunill, V., Fragkogianni, S., Clarke, L., Flicek, P., Rico, D., et al. (2016) · Cell Systems · doi:10.1016/j.cels.2016.10.021 · Cited by 151
The role of the FPR2/ALX receptor in atherosclerosis development and plaque stability
Petri, M. H., Laguna-Fernández, A., Gonzalez-Diez, M., Paulsson-Berne, G., Hansson, G. K., & Bäck, M. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvu224 · Cited by 125
Aspirin‐triggered lipoxin A4 inhibits atherosclerosis progression in apolipoprotein E−/− mice
Petri, M. H., Laguna‐Fernandez, A., Arnardottir, H., Wheelock, C. E., Perretti, M., Hansson, G. K., & Bäck, M. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13707 · Cited by 120
A role for lipoxin A4 as an anti-inflammatory mediator in the human endometrium
Macdonald, L. J., Boddy, S. C., Denison, F. C., Sales, K. J., & Jabbour, H. N. (2011) · Reproduction · doi:10.1530/rep-11-0021 · Cited by 65
“Lipoxin A4 has been shown to bind to and activate the G protein-coupled receptor formyl peptide receptor 2 (FPR2/ALX), a member of the FPR family (Ye et al. 2009).”
BackgroundWen, X., Xu, X., Sun, W., Chen, K., Pan, M., Wang, J. M., Bolland, S. M., & Jin, T. (2019) · Molecular Biology of the Cell · doi:10.1091/mbc.e18-06-0358 · Cited by 30
Self-citationZhang, H., Wang, D., Gong, P., Lin, A., Zhang, Y., Ye, R. D., & Yu, Y. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-180823 · Cited by 26
Self-citationTrojan, E., Tylek, K., Schröder, N., Kahl, I., Brandenburg, L.-O., Mastromarino, M., Leopoldo, M., Basta-Kaim, A., & Lacivita, E. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02543-2 · Cited by 26
Buss, N. A. P. S., Gavins, F. N. E., Cover, P. O., Terron, A., & Buckingham, J. C. (2015) · The FASEB Journal · doi:10.1096/fj.14-268375 · Cited by 23
Tanaka, F., Mazzardo, G., Salm, D. C., de Oliveira, B. H., Joaquim, L., Machado, R. S., Cidreira, T., Petronilho, F. C., Bittencourt, E. B., Bianco, G., et al. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.08.004 · Cited by 4
Metadata
- Authors
- Ye, R. D., Boulay, F., Wang, J. M., Dahlgren, C., Gerard, C., Parmentier, M., Serhan, C. N., & Murphy, P. M.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2009-06
- Volume
- 61
- Issue
- 2
- Pages
- 119-161
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2131896212
- Cited by
- 764
- References
- 330
- FWCI
- 21.03
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.